West Coast, New England Lead in Life Science Capital Projects

---

Researched by Industrial Info Resources (Sugar Land, Texas)--U.S. and Canadian capital life science projects remain robust. There are about 1,800 major capital projects, worth about US$129 billion, in the two countries.

The West Coast and New England lead in total investment value (TIV), with 275 projects worth US$21.4 billion, and 216 projects worth US$21 billion, respectively. These regions are followed by the Northeast, with 182 projects worth US$19.5 billion; the Mid-Atlantic, with 241 projects worth US$18.1 billion; the Great Lakes, with 253 projects worth $16 billion; the Southeast, with 198 projects worth US$9.4 billion; the Midwest, with 116 projects worth US$6.1 billion, and the Southwest, with 105 projects worth US$6 billion.

Ontario has the largest TIV in Canada, with 53 projects worth US$3.1 billion. Subscribers to Industrial Info's Global Market Intelligence (GMI) Pharmaceutical & Biotech Project Reports can click here for a list of detailed project reports.

Click on the image at right for a chart showing capital project spending activity in each market region of the U.S. and Canada.

By top region, high-value projects include:

• New England: Wuxi Biologics USA LLC's (East Windsor, New Jersey) US$300 million Bulk Biologics Facility in Worcester, Massachusetts. Subscribers can click here for project details.
• West Coast: Agenus Incorporated's (NASDAQ:AGEN) (Lexington, Massachusetts) US$400 million Antibodies and Cell Therapy campus in Vacaville, California. Click here to learn more.
• Northeast: Regeneron's (NASDAQ:REGN) (Westchester County, New York) US$480 million Research & Development Campus Expansion in Tarrytown, New York. Click here for more information.
• Mid-Atlantic: Spark Therapeutics Incorporated's (Philadelphia, Pennsylvania) $US575 Gene Therapy Innovation Center Contract Development and Manufacturing Organization (CDMO) in Philadelphia, Pennsylvania. Click here for the project report.
• Ontario, Canada: National Resilience Incorporated's US$333 million MRNA Fill and Finish CDMO expansion in Mississauga. Click here for the project report.

Subscribers to Industrial Info's GMI Project Database can click here for a full list of detailed reports for projects mentioned in this article, and click here for a full list of related plant profiles.

Industrial Info Resources (IIR) is the leading provider of industrial market intelligence. Since 1983, IIR has provided comprehensive research, news and analysis on the industrial process, manufacturing and energy related industries. IIR's Global Market Intelligence (GMI) helps companies identify and pursue trends across multiple markets with access to real, qualified and validated plant and project opportunities. Across the world, IIR is tracking over 200,000 current and future projects worth $17.8 Trillion (USD).